Premium Quality Recombinant Human Kallikrein 4/klk4 Protein (his Tag) Kit [MBKluQVR]

Premium Quality Recombinant Human Kallikrein 4/klk4 Protein (his Tag) Kit [MBKluQVR]

Introducing our high-quality Premium Quality Recombinant Human Kallikrein 4/klk4 Protein (his Tag) Kit [MBKluQVR], a cutting-edge research tool designed for scientists and researchers in the field of molecular biology. This protein, derived from HEK293 cells, is a powerful tool for studying the role of Kallikrein 4 in various biological processes, including carcinogenesis and tumor suppression. With its high purity and specific tag, this protein is ideal for a wide range of applications in both research and diagnostic settings.

Product Specifications and Properties

Our Premium Quality Recombinant Human Kallikrein 4/klk4 Protein (his Tag) Kit [MBKluQVR] is produced using a state-of-the-art expression system, ensuring optimal yield and purity. Key features include:

• Purity: > 95% as determined by reducing SDS-PAGE.
• Endotoxin: < 1.0 EU per μg of the protein as determined by the LAL method.
• Storage: Stable for up to 12 months when stored at -20 to -80℃.
• Shipping: Provided as lyophilized powder with ice packs for safe delivery.

This protein is also available in a convenient formulation, with 5% - 8% trehalose, mannitol, and 0.01% Tween 80 added as protectants before lyophilization, ensuring its stability and ease of use.

Applications and Benefits

The Premium Quality Recombinant Human Kallikrein 4/klk4 Protein (his Tag) Kit [MBKluQVR] is a versatile tool for a wide range of research applications. It is particularly useful in studying the role of Kallikrein 4 in breast and prostate cancers, as well as in the development of novel cancer biomarkers. This protein is also suitable for use in diagnostic assays, enzyme-linked immunosorbent assays (ELISAs), and other immunoassays. By using our high-quality Kallikrein 4 protein, researchers can gain valuable insights into the complex mechanisms of various diseases and contribute to the development of new therapeutic strategies.